The Production of Tumor Necrosis Factor in Cells of Tumor-Bearing Mice After Total-Body Microwave Irradiation and Antioxidant Diet

References

• Brown T. D., Goodman P., Fleming T., Macdonald J. S., Hersh E. M., Braun T. J. A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: a South-West Oncology Group study. J. Immunother. 1991; 10: 376–378
   PubMed Web of Science ®Google Scholar
• Burke F. Cytokines (IFNs, TNF-α, IL-2 and IL-12) and animal models of cancer. Cytokines, Cell. Mol. Ther. 1999; 5: 51–61, [CSA]
   PubMedGoogle Scholar
• Byers P. G. Dietary carotenes, vitamin C and vitamin E as protective antioxidants in human cancers. Ann. Rev. Nutr. 1992; 12: 139–159, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cifone M. G., Alesse E., Reale M., Fieschi C., Bologne M., Fiore S., Conti P. Effect of rhuTNF-α on TXB2 release by macrophages. Int. J. Tissue React. 1987; 9: 51–53
   PubMedGoogle Scholar
• Corti A., Marcucci F. Tumor necrosis factor: strategies for improving the therapeutic index. J. Drug Target 1998; 5: 403–413, [CSA]
   PubMed Web of Science ®Google Scholar
• De Vita F., Orlitura M., Auriemma A., Infusino S., Catalano G. Serum concentration of proinflammatory cytokines in advanced non small cell lung cancer patients. Exp. Clin. Cancer Res. 1998; 17: 413–417, [CSA]
   PubMed Web of Science ®Google Scholar
• De Vries M. R., Borel Rinkes I. H., Swaak A. J., Hack C. E., Van De Velde C. J., Wiggers T., Nollenaar R. A., Kuppen P. J., Eggermont A. M. Acute-phase response patterns in isolated hepatic perfusion with tumor necrosis factor α (TNF-α) and melphalan in patients with colorectal liver metastases. Eur. J. Clin. Invest. 1999; 29: 553–560, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Fairflied K. M., Hankinson S. E., Rosner B. A., Hunter D. J., Colditz G. A., Willett W. C. Risk of ovarian carcinoma and consumption of vitamins A, C, and E and specific carotenoids: a prospective analysis. Cancer 2001; 92: 2318–2326, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fesenko E. E., Makar V. R., Novoselova E. G., Sadovnikov V. B. Microwaves and cellular immunity. I. Effect of whole body microwave irradiation on tumor necrosis factor production in mouse cells. Bioelectrochem. Bioenerg. 1999; 49: 30–36, [CROSSREF]
   Web of Science ®Google Scholar
• Friess H., Ono X.-Z., Nan B.-C., Kleeff O., Buchler M. W. Growth factors and cytokines in pancreatic carcinogenesis. Ann. NY Acad. Sci. 1999; 880: 110–121
   PubMed Web of Science ®Google Scholar
• Furia L., Hill D. W., Gandhi O. P. Effect of millimeter-wave irradiation on growth of Saccharamyces cerevusuae. IEEE Trans. Biomed. Eng. 1983; 33: 993–999
   Google Scholar
• Gerber M. Protective vegetal micronutrients and microcomponents for breast cancer. Bull. du Cancer 2001; 88: 943–953
   PubMed Web of Science ®Google Scholar
• Jourdan M., Tarte K., Legouffe E., Brochier J., Rossi J. F., Klein B. Tumor necrosis factor is a survival and proliferation factor for human myeloma cells. Eur. Cytokine Network 1999; 10: 65–70, [CSA]
   PubMed Web of Science ®Google Scholar
• Karayiannakis A. J., Syrigos K. N., Polychronidis A., Pitiakoudis M., Bounovas A., Simopoulos K. Serum levels of tumor necrosis factor-α and nutritional status in pancreatic cancer patients. Anticancer Res. 2001; 21: 1355–1358, [CSA]
   PubMed Web of Science ®Google Scholar
• Katschinski D. M., Robins H. I., Schad M., Frede S., Fandrey J. Role of tumor necrosis factor-α in hyperthermia-induced apoptosis of human leukemia cells. Cancer Res. 1999; 59: 3404–3410
   PubMed Web of Science ®Google Scholar
• Liboff A. R., McLeod B. R., Smith S. D.. Method and Apparatus for the Treatment of Cancer. US Patent 4,932,951, 1990
   Google Scholar
• Liboff A. R., McLeod B. R., Smith S. D.. Method and Apparatus for the Treatment of Cancer. US Patent 5,437,600, 1995
   Google Scholar
• Novoselova E. G., Fesenko E. E., Makar V. R., Sadovnikov V. B. Microwaves and cellular immunity. II. Immunostimulating effects of microwaves and naturally occurring antioxidant nutrients. Bioelectrochem. Bioenerg. 1999; 49: 37–41, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Okabe S., Suganuma M., Ochiani Y., Sueoka E., Kohya H., Takanashi M., Mizutani M., Matsuzaki T., Fujiki H. Disaccharide esters screened for inhibition of tumor necrosis factor-α release are new anti-cancer agents. Japanese J. Cancer Res. 1999; 90: 669–676, [CSA]
   PubMedGoogle Scholar
• Schwartz J. L., Shklar G., Trickler D. p53 in the anticancer mechanism of vitamin E. Eur. J. Cancer Part B Oral. Oncol. 1993a; 29B: 313–318, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schwartz J. L., Antoniades D. Z., Zhao S. Molecular and biochemical reprogramming of oncogenesis through the activity of prooxidants and antioxidants. Ann. NY Acad. Sci. USA 1993b; 278: 262–278
   Google Scholar
• Sherman M. L., Datta R., Hallahan D. E., Weichselbaum R. R., Kufe D. W. Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloma cells and peripheral blood monocytes. J. Clin. Invest. 1991; 87: 1794–1797, [CSA]
   PubMed Web of Science ®Google Scholar
• Socher S. H., Martinez D., Craig J. B., Kuhn J. G., Oliff A. Tumor necrosis factor not detectable in patients with clinical cancer cathexia. J. Natl. Cancer Inst. 1988; 80: 595–598
   PubMed Web of Science ®Google Scholar
• Tabata Y., Noda Y., Matsui Y., Ikada Y. Targeting of tumor necrosis factor to tumor by use of dextran and metal coordination. J. Control. Release 1999; 59: 187–196, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Vassalli P. The pathophysiology of tumor necrosis factor. Ann. Rev. Immun. 1991; 10: 411–452, [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Vrouenraets B. C., Eggermont A. M., Hart A. A., Klaase J. M., van Geel A. N., Nieweg J. E., Kroon B. B. Regional toxicity after isolated limb perfusion with melphtalan and tumor necrosis fact—α versus toxicity after melphtalan alone. Eur. J. Surg. Oncol. 2001; 27: 390–395, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Wu P. C., Alexander Y. R., Huang J., Hwu P., Gnant M., Berger A. C., Turner E., Wilson O., Libutti S. K. In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-α is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAP II). Cancer Res. 1999; 59: 205–212
   PubMed Web of Science ®Google Scholar
• Wysocki L. J., Sato V. L. “Panning” for lymphocytes: a method for cell selection. Proc. Natl. Acad. Sci. USA 1987; 75: 2844–2848
   Google Scholar
• Yamauchi N., Watanabe H., Neda H., Maeda M., Niitsu Y. Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing tumor cells in vitro. Cancer Res. 1989; 49: 1671–1675
   PubMed Web of Science ®Google Scholar